{"id":"https://openalex.org/A5069075897","orcid":"https://orcid.org/0000-0001-8701-5472","observed_orcids":["https://orcid.org/0000-0001-8701-5472"],"display_name":"Anna S. Tashchilova","raw_author_names":["A. S. Tashchilova","A.S. Tashchilova","Anna S. Tashchilova","Anna Tashchilova","Tashchilova, A. S."],"full_name":"Anna S. Tashchilova","works_count":15,"cited_by_count":112,"summary_stats":{"2yr_mean_citedness":4.0,"h_index":6,"i10_index":4},"ids":{"openalex":"https://openalex.org/A5069075897","orcid":"https://orcid.org/0000-0001-8701-5472","observed_orcids":["https://orcid.org/0000-0001-8701-5472"]},"affiliations":[{"institution":{"id":"https://openalex.org/I19880235","ror":"https://ror.org/010pmpe69","display_name":"Lomonosov Moscow State University","country_code":"RU","type":"education","lineage":["https://openalex.org/I19880235"]},"years":[2024,2023,2022,2021,2020,2019]},{"institution":{"id":"https://openalex.org/I4210125717","ror":"https://ror.org/03ad6jw85","display_name":"State Research Institute of Highly Pure Biopreparations","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210125717"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I4405263717","ror":"https://ror.org/059yv9j77","display_name":"Federal State Budgetary Institution \"Centre for Strategic Planning and Management of Biomedical Health Risks\" of the Federal Medical and Biological Agency","country_code":"RU","type":"government","lineage":["https://openalex.org/I4405263717","https://openalex.org/I64264942"]},"years":[2026,2025]},{"institution":{"id":"https://openalex.org/I64264942","ror":"https://ror.org/052ay8m85","display_name":"Federal Medical-Biological Agency","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210125717","ror":"https://ror.org/03ad6jw85","display_name":"State Research Institute of Highly Pure Biopreparations","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210125717"]},{"id":"https://openalex.org/I4405263717","ror":"https://ror.org/059yv9j77","display_name":"Federal State Budgetary Institution \"Centre for Strategic Planning and Management of Biomedical Health Risks\" of the Federal Medical and Biological Agency","country_code":"RU","type":"government","lineage":["https://openalex.org/I4405263717","https://openalex.org/I64264942"]},{"id":"https://openalex.org/I64264942","ror":"https://ror.org/052ay8m85","display_name":"Federal Medical-Biological Agency","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]}],"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":12,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":6,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","count":4,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","count":3,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","count":3,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":5.04e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","value":3.26e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":2.96e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":2.95e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12254","display_name":"Machine Learning in Bioinformatics","value":1.37e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","score":0.792248010635376},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.750871479511261},{"id":"21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","score":0.5178737640380859},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.5041000247001648},{"id":"159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","score":0.0}],"counts_by_year":[{"year":2019,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2020,"works_count":1,"oa_works_count":1,"cited_by_count":7},{"year":2021,"works_count":2,"oa_works_count":1,"cited_by_count":9},{"year":2022,"works_count":3,"oa_works_count":2,"cited_by_count":16},{"year":2023,"works_count":2,"oa_works_count":1,"cited_by_count":20},{"year":2024,"works_count":1,"oa_works_count":0,"cited_by_count":19},{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":11},{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":30}],"display_name_alternatives":["A. S. Tashchilova","A.S. Tashchilova","Anna S. Tashchilova","Anna Tashchilova","Tashchilova, A. S."],"block_key":"a tashchilova","works_api_url":"https://api.openalex.org/works?filter=author.id:A5069075897","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5069075897","updated_date":"2026-11-12T13:17:38","created_date":"2019-12-13T00:00:00"}